Added to YB: 2024-12-23
Pitch date: 2024-10-10
VRTX [bullish]
Vertex Pharmaceuticals Incorporated
-5.54%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).
Market Cap
$108.3B
Pitch Price
$478.53
Price Target
N/A
Dividend
N/A
EV/EBITDA
20.02
P/E
30.01
EV/Sales
8.37
Sector
Biotechnology
Category
growth
Show full summary:
Brown Capital Management Small Company Fund New Position: Vertex Pharmaceuticals Incorporated
VRTX: Enterprise software for indirect tax compliance. 60%+ Fortune 500 clients. Mid-teens revenue growth, expecting similar for 3-5 years. Large market, growing on global tax complexity. Sticky, mission-critical product. Profitable soon, margin expansion potential. Leading in enterprise market.
Read full article (1 min)